Question

In: Electrical Engineering

covert -19.875 to the following: i) Two's complement ii) Octal iii) Hexadecimal iv) Gray code

covert -19.875 to the following:

i) Two's complement

ii) Octal

iii) Hexadecimal

iv) Gray code

Solutions

Expert Solution


Related Solutions

2014 I 31 2017 I 69 II 24 II 54 III 23 III 46 IV 16...
2014 I 31 2017 I 69 II 24 II 54 III 23 III 46 IV 16 IV 32 2015 I 42 2018 I 82 II 35 II 66 III 30 III 51 IV 23 IV 38 2016 I 53 2019 I 91 II 45 II 72 III 39 III 59 IV 27 IV 41 Create a multiple regression equation incorporating both a trend (t=0 in 2013: IV) and dummy variables for the quarters. Let the first quarter represent the reference...
2014 I 31 2017 I 69 II 24 II 54 III 23 III 46 IV 16...
2014 I 31 2017 I 69 II 24 II 54 III 23 III 46 IV 16 IV 32 2015 I 42 2018 I 82 II 35 II 66 III 30 III 51 IV 23 IV 38 2016 I 53 2019 I 91 II 45 II 72 III 39 III 59 IV 27 IV 41 Create a multiple regression equation incorporating both a trend (t=0 in 2013: IV) and dummy variables for the quarters. Let the first quarter represent the reference...
8. Use the following table to answer questions I, ii, iii and iv A B C...
8. Use the following table to answer questions I, ii, iii and iv A B C Initial cost $15,000 $9,000 $12,000 Annual benefit $8,000 $2,000 $1,800 Salvage value $5,000 $9,000 0 Life in years 2 years 3 Years Infinity MARR 10% i. The NPW of alt. A is __________________. A) $13,420 B) $17,380 C) $11,000 D) $6,00 ii. The NPW of alt. B is __________________. A) $13,420 B) $17,380 C) $11,000 D) $6,000 iii. The NPW of alt. C is...
Describe the insertion of type I, II, III and IV into the ER membrane? Differences?
Describe the insertion of type I, II, III and IV into the ER membrane? Differences?
Explain the following in relation to antiretroviral therapy: i. Pharmacodynamics ii. Pharmacokinetics iii. Pharmacogenomics iv. Drug...
Explain the following in relation to antiretroviral therapy: i. Pharmacodynamics ii. Pharmacokinetics iii. Pharmacogenomics iv. Drug availability during contraception use and pregnancy v. Drug-drug interactions during treatment
explain the following Neurotransmitters: i. Serotonin ii. Histamine iii. Dopamine ( 5 marks each ) iv....
explain the following Neurotransmitters: i. Serotonin ii. Histamine iii. Dopamine ( 5 marks each ) iv. Glycine v. Glutamate vi. Gama amino butyric acid (GABA) vii. Nitric oxide (NO)
Which of the following 0.10 M salt solutions are basic? I. Na2CO3    II. NH4Br         III. KNO3           IV....
Which of the following 0.10 M salt solutions are basic? I. Na2CO3    II. NH4Br         III. KNO3           IV. LiF A. I and III B. II and IV C. I and IV D. II and III
Explain about the following (i) Ordinary shares (ii) Preference shares (iii) Cost of capital (iv) Weighted...
Explain about the following (i) Ordinary shares (ii) Preference shares (iii) Cost of capital (iv) Weighted average cost of capital (WACC)
In Toxicity and Hypersensitivity, What are the differences between Types I, II,III, and IV hypersensitivities including
In Toxicity and Hypersensitivity, What are the differences between Types I, II,III, and IV hypersensitivities including why they occur and cells (mechanisms) they utilize
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT